$PASG
Passage BIO, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Philadelphia, PA
PASG chart
What traders are saying about $PASG
Latest postsPassage BIO, Inc. news
- Passage Bio Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Passage Bio Q3 2026 Earnings Results and Report
MarketBeat ·
- Passage Bio Reports Q3 2026 Financials: Cash Reserves Drop to $20.16M, Operating Leases Fully Terminated
Kalkine Media ·
- PASG: Passage Bio agrees to merge with Remix Therapeutics
Quantisnow ·
- Passage Bio 3Q 2026: EPS ($1.47) — 10-Q Summary
TradingView ·
- Gene-therapy programs are winding down as Passage Bio (PASG) warns its cash may fall short.
Stock Titan ·
- Passage Bio Q3 2026 Earnings Date and Estimates
MarketBeat ·
- Passage Bio shareholders approve merger with Remix Therapeutics and reverse stock split
Investing.com Canada ·
- Remix to go public in reverse merger with once high-flying Passage Bio
biopharmadive.com ·
- SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today
stocktwits.com ·
- PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff?
stocktwits.com ·
- Passage Bio and Remix Therapeutics Announce Merger Agreement
Yahoo Finance ·
Passage BIO, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$45.5M | -$64.8M | -$102.1M | -$136.1M |
| Diluted EPS | $-14.35 | $-21.04 | $-1.86 | $-2.50 |
| Total assets (year end) | $62.3M | $102.4M | $150.5M | $243.5M |
| Cash and equivalents (year end) | $46.3M | $37.6M | $21.7M | $34.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Passage BIO, Inc.
- Ticker
- PASG (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Philadelphia, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1787297
Frequently asked questions
What exchange is Passage BIO, Inc. listed on?
Passage BIO, Inc. trades on the Nasdaq under the ticker symbol PASG.
What industry is Passage BIO, Inc. in?
Passage BIO, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Passage BIO, Inc. headquartered?
Passage BIO, Inc.'s business address on file with the SEC is in Philadelphia, PA.
When does Passage BIO, Inc.'s fiscal year end?
Passage BIO, Inc.'s fiscal year ends on December 31.